A Look At Billion-Dollar Deals For ChemChina And Pfizer

The United States government has signed off on ChemChina's $43 billion acquisition of Syngenta, one of the world's biggest agricultural chemical and seed producers. When the deal is finalized, it will be China's biggest-ever foreign acquisition.

Another major acquisition is also in the works, with Pfizer agreeing to buy the biotech company Medivation — which makes a leading cancer drug — for $14 billion.

Here & Now's Meghna Chakrabarti speaks with Jill Schlesinger of CBS News about the acquisitions.

Jill Schlesinger, CBS News business analyst and host of "Jill on Money." She tweets @jillonmoney.